Table 1. Patients and disease characteristics at baseline.

Characteristics	N=57 (%)
Sex
Male	35 (61.4)
Female	22 (38.6)
Age (years)
Median [range]	55 [18–81]
<60	39 (68.4)
60–70	15 (26.3)
>70	3 (5.3)
Histology
Liposarcoma	30 (52.6)
Leiomyosarcoma	8 (14.0)
Rhabdomyosarcoma	3 (5.3)
Fibrosarcoma	2 (3.5)
Aggressive fibromatosis	2 (3.5)
DSRCT	2 (3.5)
MPNST	2 (3.5)
SMFT	2 (3.5)
UPS	1 (1.8)
Synovial sarcoma	1 (1.8)
Malignant paraganglioma	1 (1.8)
High-grade sarcomas (NOS)	3 (5.3)
FNCLCC grade
G1	11 (19.3)
G2	24 (42.1)
G3	22 (38.6)
Type of disease
Local advanced	39 (68.4)
Metastases [peritoneum/LN/liver/lung]	18 (31.6) [10/1/4/8]
Prior surgery
Yes	38 (66.7)
No	19 (33.3)
Treatment
First-line therapy	53 (93.0)
Second-line therapy	4 (7.0)

Data shown are numbers and percentage of patients or median and range values with available data. DSRCT, desmoplastic small round cell tumor; MPNST, malignant peripheral nerve sheath tumor; SMFT, solitary malignant fibrous tumor; UPS, undifferentiated pleomorphic sarcoma; NOS, not otherwise specified; FNLCC, Fédération Nationale des Centres de Lutte Contre le Cancer; LN, lymph node.